The Clinicians Speak, page-1052

Another excellent paper describing the versatility of use of Novosorb BTM referencing at least 62 papers with the expected conclusion and should help convincing other Doctors thinking about BTM!!

We describe to date the largest clinical series utilizing SPM in the United States. This matrix was successfully used in a large number of patients with burns, trauma and chronic wounds. Despite the presence of active smoking, diabetes, complex social histories, microbial colonization or wound infection, there was greater than 95 % matrix and skin graft survival in more than 80 % of patients. However, the median time from matrix placement to STSG was 5 weeks. This study demonstrates the robustness of this skin substitute to achieve successful reconstruction even in the setting of adverse patient or wound characteristics

https://www.sciencedirect.com/science/article/pii/S2468912224000609